Corvair vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

Corvair specializes in AI-powered analysis of resting diagnostic ECGs, providing interpretations for cardiac rhythm and morphology. In contrast, Autoplaque focuses on quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction. While both are cardiology AI tools, they utilize different diagnostic modalities and address distinct aspects of cardiac assessment.

Choose Corvair if…

Choose Corvair if you need an FDA-cleared AI ECG analysis system to rapidly assist in the interpretation of resting diagnostic ECGs. This tool is ideal for healthcare professionals requiring quick, comprehensive analysis of cardiac electrical activity, offering 35 determinations for rhythm and morphology to enhance diagnostic confidence.

View Corvair →

Choose Autoplaque if…

Choose Autoplaque if your primary need is detailed, quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is best suited for cardiologists and radiologists focused on assessing heart attack risk and guiding treatment strategies based on precise anatomical pathology.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Corvair Autoplaque
Deployment Cloud, Mobile App Workstation-based post-processing application, runs on Windows or Mac OS.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Corvair

Corvair, as a cloud-based Software as a Medical Device (SaMD) operating as an API, offers flexible integration into diverse clinical workflows and devices, simplifying data acquisition with its 4-lead ECG requirement. While Autoplaque provides detailed workstation-based analysis with clinician review and editing capabilities, its deployment model may be less universally accessible or integrated compared to Corvair's cloud-native approach.

Clinical Value

Autoplaque

Autoplaque provides highly detailed, quantitative AI-powered analysis of coronary plaque morphology and luminal stenoses from CT angiography, which is crucial for precise heart attack risk prediction and treatment guidance. While Corvair offers broad ECG interpretation for immediate cardiac assessment, Autoplaque's specialized, objective plaque characterization represents a deeper and more advanced diagnostic capability in a complex clinical area.

Pricing & Value

Tie

Neither Corvair nor Autoplaque provides transparent pricing information, with both requiring direct contact with the vendor for details. Without any disclosed costs or publicly available cost-benefit analyses, it is impossible to conduct a meaningful comparison of their pricing or overall value.

Enterprise Readiness

Corvair

Corvair explicitly states HIPAA compliance, BAA availability, and ISO 42001 certification, alongside its cloud-based deployment and robust integration options via EHR, SDK, and API. These factors indicate a higher level of readiness for secure, scalable, and compliant deployment within large healthcare enterprises compared to Autoplaque, which does not specify BAA or HIPAA compliance in the provided information.

Innovation

Autoplaque

Autoplaque demonstrates greater innovation by offering precise, quantitative AI-powered analysis of coronary plaque morphology and stenosis from CT angiography, moving beyond qualitative assessment to objective measurements for risk prediction. This detailed characterization of plaque components, such as low-attenuation noncalcified plaque, represents a significant advancement in cardiovascular imaging diagnostics for predicting adverse cardiac events.

Support & Docs

Corvair

AliveCor, the company behind Corvair, provides clear and accessible customer support channels including email, phone, and a dedicated request submission portal, along with 'Getting Started' resources. While Autoplaque likely includes user manuals, explicit details regarding its customer support infrastructure, service level agreements, or comprehensive public documentation are not as readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Corvair Autoplaque
Tool Name Corvair Autoplaque
Company AliveCor Cedars-Sinai Medical Center: AIM
Primary Function AI ECG analysis system that assists healthcare professionals in interpreting resting diagnostic ECGs AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images
Input Data Type Standard diagnostic-bandwidth ECG recordings (wet Ag/AgCl electrodes), 10-second ECGs CT Angiographic images
Key Output/Determinations 35 cardiac determinations (14 rhythm, 21 morphology) Quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, analysis of coronary anatomy and pathology
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Corvair and Autoplaque.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Corvair by AliveCor is an AI ECG analysis system that interprets resting diagnostic ECGs. Autoplaque, developed by Cedars-Sinai AIM, is an AI-powered software designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images.
Corvair provides 35 cardiac determinations, including 14 rhythm and 21 morphology findings, to assist healthcare professionals in interpreting resting diagnostic ECGs. Autoplaque offers AI-powered quantitative analysis for the detection, characterization, and measurement of atherosclerotic plaque and luminal stenoses from CT angiographic images, aiding in heart attack risk prediction and treatment guidance.
Corvair is explicitly HIPAA compliant, offers a Business Associate Agreement (BAA), and is ISO 42001 certified for its AI Management System. For Autoplaque, HIPAA compliance and BAA availability are not specified in the provided information, though an older version of Autoplaque was noted as HIPAA compliant in a 2010 study.
Corvair is designed for Cardiology, Emergency Medicine, and Internal Medicine, assisting healthcare professionals with ECG interpretation. Autoplaque is primarily for Cardiology and Radiology, aiding in the analysis of CT angiography images for heart attack risk prediction and treatment guidance.
Corvair requires standard diagnostic-bandwidth ECG recordings using wet Ag/AgCl electrodes and only 4 ECG leads for its 10-second ECG analysis. Autoplaque requires CT angiography images for its quantitative analysis of coronary plaques and luminal stenoses.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.